Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A dyskeratosis congenita that has material basis in an autosomal recessive mutation of TERT on chromosome 5p15.33.
Biomarker and diagnostic research for autosomal recessive dyskeratosis congenita 4 has been reported in the published literature.
No clinical trials have been registered for autosomal recessive dyskeratosis congenita 4.
3 publications have been identified in PubMed for autosomal recessive dyskeratosis congenita 4. Research spans Case Report / Case Series (67%) and Diagnostic / Biomarker (33%).
Soni J (2026). [PMID: 41741124](https://pubmed.ncbi.nlm.nih.gov/41741124/). *BMJ case reports*. [Case Report / Case Series]
de Almeida Junior HL (2025). [PMID: 41192028](https://pubmed.ncbi.nlm.nih.gov/41192028/). *Anais brasileiros de dermatologia*. [Diagnostic / Biomarker]
Shah A (2025). [PMID: 39939801](https://pubmed.ncbi.nlm.nih.gov/39939801/). *Journal of human genetics*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:36 PM UTC